Paper Review Records
全部论文审稿周期
20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
210
天
Small‐Molecule Protein Kinase Inhibitors Approved by the U.S. FDA as Anticancer Agents From 2021 to 2025
作者
Qi‐Qi Chen; Yan‐Bo Li; Jin‐Bo Niu; Chen‐Zheng Huang; Yan Xu; Jian Song; Sai‐Yang Zhang展开收起
作者单位
1. School of Basic Medical Sciences Zhengzhou University Zhengzhou Henan China; 2. The First Clinical Medical College Zhengzhou University Zhengzhou Henan China; 3. The Third Affiliated Hospital of Zhengzhou University Zhengzhou Henan China展开收起
153
天
PI3K Inhibitors in Cancer Therapy: Recent Advances and Future Perspectives
作者
He‐Nan Liu; Cuishan Guo; Ying Zhu; Qifang Liu; Hui Li; Jiao Yin; Pin Cao; Huijie Zhang; Qingqing Chen展开收起
作者单位
1. Department of Ophthalmology Shengjing Hospital of China Medical University Shenyang Liaoning China; 2. Department of Obstetrics and Gynecology Shengjing Hospital of China Medical University Shenyang Liaoning China; 3. Department of Neurology The First Hospital of China Medical University Shenyang Liaoning China; 4. China Medical University Shenyang Liaoning China展开收起
269
天
Host‐Directed Ferroptotic Stress Modulation Against Intracellular Bacterial Infections: Mechanisms, Evidence, and Translational Challenges
作者
Youle Zheng; Jin Feng; Qinyuan Chang; Tong Wang; Qianwei Qu; Yanhua Li展开收起
作者单位
1. College of Veterinary Medicine Northeast Agricultural University Harbin China; 2. Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development Harbin China; 3. Key Laboratory of the Provincial Education Department of Heilongjiang for Common Animal Disease Prevention and Treatment Northeast Agricultural University Harbin China展开收起
139
天
Noncanonical Roles of Metabolites in Disease Progression and Precision Medicine
作者
Qi Wu; Xuelu Xie; Sheng He; Yanting Liu; Yinghua Ji; Ping Lu; Wenyong Yang; Jingwen Jiang展开收起
作者单位
1. West China School of Public Health and West China Fourth Hospital, State Key Laboratory of Biotherapy, Sichuan University Tianfu Jincheng Laboratory Chengdu China; 2. Department of Ophthalmology, West China School of Public Health and West China Fourth Hospital Sichuan University Chengdu China; 3. Department of General Surgery, Colorectal Cancer Center, West China Hospital Sichuan University Chengdu Sichuan China; 4. Department of Oncology The First Affiliated Hospital of Xinxiang Medical University Weihui Henan Province China; 5. Department of Neurosurgery, Medical Research Center, The Affiliated Hospital of Southwest Jiaotong University The Second Chengdu Hospital Affiliated to Chongqing Medical University, The Third People's Hospital of Chengdu Chengdu China展开收起
169
天
The Neurovascular Unit in Diabetic Retinopathy: The Emerging Role of Pyroptosis and Therapeutic Prospects
作者
Yongzhuo Yu; Shufa Li; Zeng Li; Wenqing Ren; Lili Xu; Yangang Wang; Bingzi Dong展开收起
作者单位
1. Department of Endocrinology and Metabolism The Affiliated Hospital of Qingdao University Qingdao Shandong China展开收起
127
天
Chemical Modulation of the cGAS‐STING‐ENPP1 Axis: Medicinal Chemistry and Clinical Perspective
作者
Akash U. Shinde; Sandip B. Bharate展开收起
作者单位
1. Department of Natural Products & Medicinal Chemistry CSIR‐Indian Institute of Chemical Technology Hyderabad India; 2. Academy of Scientific & Innovative Research (AcSIR) Ghaziabad India展开收起
FAQ
MEDICINAL RESEARCH REVIEWS审稿要多久?
截至2026-11-17,CrushSCI 收录了 MEDICINAL RESEARCH REVIEWS 的 20 篇完整审稿记录。最快一篇从收稿到录用用了 101 天(Landscape of Endocytic Effectors for Extracellular Targeted Protein Degradation,2026-06-16 收稿,2026-09-25 录用),最慢一篇用了 540 天;平均 179.8 天,中位数 149 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
